Peptide Initiative

Dosing protocol · Cognitive

Noopept (Omberacetam) dosing & administration

Ultra-potent dipeptide nootropic and prodrug of cycloprolylglycine that enhances cognition through BDNF/NGF upregulation, AMPA receptor modulation, and multicomponent neuroprotection at doses 1000 times lower than piracetam

Suggested dose

10 mg

Twice daily (morning and afternoon)Frequency
OralRoute
12+ weeksCycle length

Dosing

How much Noopept (Omberacetam) do I take?

Oral

Oral: Taken by mouth as a capsule, tablet, or liquid.

Bioavailability Varies by compound — many peptides are largely broken down in the gut, so little reaches the blood intact; some small molecules absorb well.

  • 10 mg twice daily (20 mg/day)

    Frequency
    Twice daily (morning and afternoon)
    Duration
    56 days (8 weeks) per clinical study

    Dose used in a controlled human study of mild cognitive impairment, improving cognition with good tolerability .

Timing

Best time to take

Take Noopept (Omberacetam) at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.

With food?

Noopept (Omberacetam) can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.

If stacking

Noopept (Omberacetam) should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting your dose

Increase if

  • You've tolerated the current dose for the recommended period without significant side effects
  • Therapeutic goals haven't been met at the current dose level
  • Your healthcare provider recommends dose escalation based on your response
  • Lab work or clinical assessments support a higher dose

Decrease if

  • Side effects are bothersome or impacting daily life despite management strategies
  • You experience any signs of an adverse reaction
  • Lab results indicate the need for dose reduction
  • Your healthcare provider recommends a lower dose based on your response

Signs of right dose

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Administration

How do I use Noopept (Omberacetam)?

Reconstitution

What you need

  • Noopept (Omberacetam) in its prescribed form
  • Clean, dry storage container
  • Measuring device if applicable (oral syringe, measuring cup)
  • Calendar or reminder app for dosing schedule

Injection

Route

Noopept (Omberacetam) is administered Oral (tablet/capsule)—no injection required

Best sites

  • Not applicable—this is not an injectable formulation

Storage

Before reconstitution

Store Noopept (Omberacetam) in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Noopept (Omberacetam) should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation — discard the vial

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Sample daily schedule

  • As prescribed (multiple times daily)

    As prescribed by your healthcare provider injection

    Site: Oral (tablet/capsule)—rotate sites if applicable

    Maintain a consistent schedule for optimal results with Noopept (Omberacetam). Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is Noopept (Omberacetam) safe?

Side effects

Commonly reported: Headache, Irritability or restlessness, Sleep disturbance, Mild gastrointestinal discomfort, Vivid dreams

Less common: Blood pressure increase

Serious side effects

  • Allergic reaction

Stop and seek help if

  • Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • Your healthcare provider recommends discontinuation based on your clinical response
  • Development of any new medical condition that may be contraindicated with Noopept (Omberacetam)
  • Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • Abnormal lab results or clinical markers that suggest adverse effects

Noopept (Omberacetam) should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Flagged pairings

  • High-dose racetams simultaneously — overlapping mechanisms may cause overstimulation or diminishing returns — Use with caution—discuss with your healthcare provider.
  • Strong glutamatergic agents or AMPA potentiators — risk of excitatory overload through shared AMPA receptor modulation — Use with caution—discuss with your healthcare provider.
  • Anticholinergic medications — may counteract Noopept's cholinergic-positive effects — Use with caution—discuss with your healthcare provider.

Published research

What the studies show

  • Limited human trials
  • Research compound
  1. Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation

    Ostrovskaya RU, Vakhitova YV, Kuzmina USh · 2014PubMed

    This study investigated the properties and effects of Noopept (Omberacetam), contributing to our understanding of its mechanism of action and potential therapeutic applications.

  2. GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons

    Pelsman A, Hoyo-Vadillo C, Gudasheva TA · 2003PubMed

    This study investigated the properties and effects of Noopept (Omberacetam), contributing to our understanding of its mechanism of action and potential therapeutic applications.

  3. Noopept efficiency in experimental Alzheimer disease: cognitive deficiency caused by beta-amyloid25-35 injection into Meynert basal nuclei of rats

    Ostrovskaya RU, Belnik AP, Storozheva ZI · 2008PubMed

    This study investigated the properties and effects of Noopept (Omberacetam), contributing to our understanding of its mechanism of action and potential therapeutic applications.

  4. Physicochemical and structural analysis of N-phenylacetyl-L-prolylglycine ethyl ester (Noopept) — an active pharmaceutical ingredient with nootropic activity

    Araj SK, Szeleszczuk Ł, Gubica T · 2025PubMed

    This study investigated the properties and effects of Noopept (Omberacetam), contributing to our understanding of its mechanism of action and potential therapeutic applications.

  5. Behavioral and electrophysiological analysis of the choline-positive effect of nootropic dipeptide acylproline (GVS-111)

    Ostrovskaya RU, Mirzoev TKh, Firova FA · 2001PubMed

    This study investigated the properties and effects of Noopept (Omberacetam), contributing to our understanding of its mechanism of action and potential therapeutic applications.

  6. A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment (Noopept 10 mg twice daily, 56 days)

    Neznamov GG, Teleshova ES · 2009PubMed

Head to head

Noopept (Omberacetam) compared

Want the full picture?

The complete Noopept (Omberacetam) research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.